Denvax helps to prevent relapse & recurrence in cancer
A cancer relapse occurs because in spite of the best efforts to get rid of cancer, some cancer cells are left behind. These cancer cells remain dormant for a period of time, but eventually they continue to multiply resulting in the recurrence or relapse.
Denvax targets the disseminated cancer cells responsible for the recurrence and relapse of cancer in treated patients. To prevent cancer from coming back, our observation of 16 years suggests taking Denvax treatment at the right stage of cancer, when tumor load is minimal. Patients taking treatment soon after surgery and chemotherapy are best candidates to Denvax receive the therapy. Denvax not only prevents recurrence but also delays disease progression, by killing the residual cells responsible for cancer progression.
Denvax targets the disseminated cancer cells responsible for the recurrence and relapse of cancer in treated patients. To prevent cancer from coming back, our observation of 16 years suggests taking Denvax treatment at the right stage of cancer, when tumor load is minimal. Patients taking treatment soon after surgery and chemotherapy are best candidates to Denvax receive the therapy. Denvax not only prevents recurrence but also delays disease progression, by killing the residual cells responsible for cancer progression.
Our Doctors
Dr Jamal A. Khan, MD, Director
The Denvax Clinic
Dr Sharmin Yaqin, MD, Director
The Denvax Clinic
Dr Rakesh Reddy Jillela, MD
Consultant Radiation Oncologist
Dr J Prabhar Rao, MD
Consultant Physician
Dr Raman Yadav, MD
Consultant
The best candidates to receive Denvax are:
- Early-stage cancer patients
- Those who have undergone a recent surgery
- Patients who are in a phase of remission
The dendritic cells given in phase of remission or when the tumor load is minimal, work at killing the
micro-metastatic cells giving patients freedom from recurrence.
